lactic acid has been researched along with Lysosomal Enzyme Disorders in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tosi, G | 1 |
| Bortot, B | 1 |
| Ruozi, B | 1 |
| Dolcetta, D | 1 |
| Vandelli, MA | 1 |
| Forni, F | 1 |
| Severini, GM | 1 |
| Bourdenx, M | 1 |
| Daniel, J | 1 |
| Genin, E | 1 |
| Soria, FN | 1 |
| Blanchard-Desce, M | 1 |
| Bezard, E | 1 |
| Dehay, B | 1 |
1 review available for lactic acid and Lysosomal Enzyme Disorders
| Article | Year |
|---|---|
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Drug Carriers; Enzyme Replacement Therapy; Genetic Th | 2013 |
1 other study available for lactic acid and Lysosomal Enzyme Disorders
| Article | Year |
|---|---|
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.
Topics: 1-Methyl-4-phenylpyridinium; Acids; Alkalies; Animals; Cell Death; Dopaminergic Neurons; Humans; Hyd | 2016 |